Clinical Trials for Liposarcoma

Find clinical trials for liposarcoma. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT ID: NCT06239272

The NRSTS2021 clinical trial is studying new treatment options for young patients with a type of cancer called non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), including specific subtypes like lip...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Memphis, Tennessee, United States +2 more

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications

NCT ID: NCT05827614

This clinical trial is studying a new treatment called BBI-355, which is designed for patients with certain types of advanced cancers, such as non-small cell lung cancer, breast cancer, and bladder...

Recruiting

Phase: PHASE1 Type: interventional Locations: Charleston, South Carolina, United States, Madison, Wisconsin, United States +16 more

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

NCT ID: NCT06198296

This clinical trial is studying a new treatment for adults with certain types of solid tumors that have a specific protein called GPC3 on their surface. The researchers are using a special kind of ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

NCT ID: NCT06843967

This clinical trial is looking at a new treatment option for people with a type of cancer called liposarcoma, specifically when it is advanced, recurrent, or cannot be surgically removed. The study...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

BTX-A51 in Patients With Liposarcoma

NCT ID: NCT06414434

This clinical trial is investigating a new drug called BTX-A51 to see if it is safe and well-tolerated for patients with liposarcoma, a type of cancer that affects fatty tissues. The study is speci...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +1 more

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT ID: NCT04715191

This clinical trial is studying a new experimental treatment called CARE T cells for children and young adults with certain types of solid tumors, including liver cancer and rhabdomyosarcoma. The t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT ID: NCT04377932

This clinical trial is testing a new experimental treatment using specially modified immune cells called AGAR T cells to fight certain types of pediatric cancers, including liver cancer and other s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

NCT ID: NCT04785196

This clinical trial is studying a new combination treatment for patients with advanced liposarcoma or other advanced solid tumors. The researchers are testing a drug called APG-115 along with anoth...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China, Shanghai, , China +1 more

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

NCT ID: NCT04224064

This clinical trial is focused on finding a new and easier way to diagnose liposarcomas, a type of cancer that occurs in fat tissue. The researchers want to develop a blood test that measures speci...

Recruiting

Phase: NA Type: interventional Locations: Montpellier, , France

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT ID: NCT04557449

This clinical trial is studying a new treatment called PF-07220060 for patients with advanced solid tumors, including specific types of breast cancer, prostate cancer, lung cancer, and liposarcoma....

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +50 more

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

NCT ID: NCT04031677

This clinical trial is studying whether giving chemotherapy before surgery can help patients with high-risk retroperitoneal sarcoma, specifically types called dedifferentiated liposarcoma (DDLPS) a...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Rochester, Minnesota, United States +147 more

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

NCT ID: NCT05103631

This clinical trial is studying a new treatment for certain types of solid tumors, specifically those that test positive for a protein called GPC3, which is often found in liver cancer and other ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

NCT ID: NCT06277154

The MASCT-I clinical trial is studying a new treatment approach for patients with advanced soft tissue sarcoma, which is a type of cancer that can affect the muscles, fat, blood vessels, and other ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

NCT ID: NCT05094804

This clinical trial is studying a new treatment called OR2805, which is a type of medication known as a monoclonal antibody. It aims to see how safe and effective OR2805 is when given alone or in c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, San Antonio, Texas, United States +1 more

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

NCT ID: NCT06039046

This clinical trial is focused on understanding the experiences of patients with liposarcoma, a type of cancer that affects soft tissue. The study aims to explore how often patients complete a spec...

Not yet recruiting

Type: observational Locations: San Francisco, California, United States

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

NCT ID: NCT02275286

This clinical trial is studying the combined effects of a medication called trabectedin and radiotherapy on patients with certain types of soft tissue sarcomas, including liposarcoma and leiomyosar...

Recruiting

Phase: PHASE1 Type: interventional Locations: Zaragoza, , Spain, Madrid, , Spain +18 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions